Aegirbio AB
F:52Q
Balance Sheet
Balance Sheet Decomposition
Aegirbio AB
Aegirbio AB
Balance Sheet
Aegirbio AB
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
10
|
34
|
15
|
12
|
|
| Cash Equivalents |
0
|
10
|
34
|
15
|
12
|
|
| Total Receivables |
0
|
2
|
9
|
4
|
5
|
|
| Accounts Receivables |
0
|
0
|
7
|
2
|
0
|
|
| Other Receivables |
0
|
0
|
2
|
2
|
0
|
|
| Inventory |
0
|
0
|
25
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
0
|
|
| Total Current Assets |
0
|
13
|
68
|
19
|
17
|
|
| PP&E Net |
0
|
1
|
3
|
3
|
1
|
|
| PP&E Gross |
0
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
31
|
56
|
45
|
35
|
|
| Goodwill |
0
|
0
|
277
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
277
|
0
|
0
|
|
| Total Assets |
1
N/A
|
44
+4 547%
|
404
+815%
|
67
-83%
|
53
-21%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
4
|
6
|
5
|
0
|
|
| Accrued Liabilities |
0
|
1
|
8
|
5
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
5
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
3
|
1
|
10
|
|
| Total Current Liabilities |
0
|
5
|
19
|
17
|
10
|
|
| Long-Term Debt |
0
|
1
|
0
|
0
|
32
|
|
| Deferred Income Tax |
0
|
0
|
7
|
5
|
4
|
|
| Other Liabilities |
0
|
0
|
8
|
4
|
8
|
|
| Total Liabilities |
0
N/A
|
5
+5 171%
|
34
+543%
|
27
-20%
|
55
+102%
|
|
| Equity | ||||||
| Common Stock |
1
|
1
|
1
|
2
|
0
|
|
| Retained Earnings |
0
|
19
|
94
|
476
|
0
|
|
| Additional Paid In Capital |
0
|
57
|
463
|
514
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
1
N/A
|
39
+4 474%
|
370
+852%
|
40
-89%
|
1
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
44
+4 547%
|
404
+815%
|
67
-83%
|
53
-21%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
7
|
13
|
19
|
21
|
31
|
|